He's Ophthalmology ESG Report: Keeping the original intention with innovation and adhering to the principle of "serving the country with science and technology and benefiting the people with technology"

"I want to fundamentally solve the problem of eye health of the Chinese people, so that the mainland's ophthalmic science and technology level is at the forefront of the world." This is not only the goal of Mr. He Wei, the founder and chairman of He's Ophthalmology, who has made unremitting efforts since he founded He's Ophthalmology for more than 20 years, but also the high condensation of He's Ophthalmology's corporate vision.

Recently, Ho's Ophthalmology (301103. SZ) disclosed its first Environmental, Social and Corporate Governance (ESG) report, which showed in detail the efforts and achievements of He's Ophthalmology in technological innovation, social responsibility, talent training, environmental protection measures and corporate governance, highlighting the company's firm determination to keep its original intention with innovation and build a "digital bright city".

Adhere to the original intention of "serving the country with science and technology and benefiting the people with technology".

What is the original intention of Ho's Ophthalmology? The first sentence of the chairman's speech made it clear that the creation of He's Ophthalmology originated from the original intention of "serving the country with science and technology and benefiting the people with technology". As a model of scholar entrepreneurship, He Wei, chairman of He's Ophthalmology, has determined the strategic goal of building an eye health service ecosystem integrating medicine, education, production and research since he returned to China in the 90s to start his own business, and the name of this goal is "Guangming City". Today, the construction of "Guangming City" has taken shape, and based on this ecosystem, it has also provided strong support for Ho's Ophthalmology to realize its original intention.

How to achieve "serving the country with science and technology and benefiting the people with technology", He's Ophthalmology answered with many examples in its first ESG report.

In the process of fulfilling its social responsibilities, He's Ophthalmology actively responds to the call for common prosperity of the country, and strives to improve the accessibility of medical services in various regions with the characteristics of "health care + artificial intelligence" services, and continues to provide high-quality ophthalmic medical services for the people.

Taking the "He's Smart Eye Health Management Station" launched by He's Ophthalmology since 2019 as an example, He's Ophthalmology has established smart eye tube stations in 14 cities in Liaoning Province so far, making in-depth use of high-tech means such as artificial intelligence, big data and cloud medical technology to apply innovative technologies to the grassroots level, improve the ability of chronic disease monitoring at the grassroots level through the application of innovative technologies and the training of grassroots doctors, reduce poverty due to illness and return to poverty due to illness, help the comprehensive revitalization of rural areas, and promote the economic development of the county. With ophthalmic smart devices as the entrance, we can discover eye diseases and chronic diseases through advanced AI intelligent diagnosis, and combine online and offline ophthalmic diagnosis and treatment systems, so that everyone can screen and prevent eye diseases through ophthalmic intelligent diagnosis and treatment equipment in various institutions.

Furthermore, it is not difficult to see the company's firm belief in scientific research and innovation. In 2023, the company will become an active participant in a number of provincial and municipal scientific research projects, contributing to the continuous progress of ophthalmic medical technology. During the reporting period, He's Ophthalmology obtained 6 authorized patents, successfully applied for 6 patents, and published a total of 45 papers, including 27 SCI papers.

In 2023, Shenyang Heshi undertook two phase III, multicenter, randomized, double-blind, and positive-controlled studies sponsored by Roche, both of which have passed the on-site inspection of drug registration clinical trials by the State Food and Drug Administration. In June 2023, the Ho Institute of Ophthalmology and Ophthalmic Genomics was officially established in Boao Lecheng to carry out extensive in-depth research on ocular genomics and hereditary eye diseases. Focusing on gene therapy, in 2023, Dr. Ho's ophthalmologists collaborated with international ophthalmologists to successfully perform gene therapy for an eight-year-old visually impaired child, becoming the first patient with Lapper's congenital amaurosis to receive Luxturna gene therapy in Chinese mainland.

"In the past year, we have accelerated the process of digitalization to promote green and low-carbon development, integrated the foundation of the 'Bright City' and put forward a new goal of building a 'Digital Bright City'."

In 2023, on the basis of technology benefiting the people, Ho's Ophthalmology will keep pace with the times and incorporate more elements of artificial intelligence. In November, the company held the "Gene + AI" precision sugar control, smart medical life cycle eye health management and the second expert analysis meeting on the treatment of diabetic eye diseases, and launched the promotion plan of "Diabetic Retinopathy Risk Susceptibility Gene Testing" to provide people with accurate prevention and control of diabetes complications. In December, the project "Unattended Artificial Intelligence Myopia Early Warning System" participated by He's Ophthalmology won the second prize in the creative group of the 3rd "Entrepreneurship and Entrepreneurship" Competition.

"Serving the country with science and technology, benefiting the people with technology" is not limited to ophthalmic medical services, with continuous cultivation in the field of ophthalmic clinical technology and scientific research, Ho's Ophthalmology can not be ignored in helping the development of the ophthalmology industry.

In 2023, Ho's Ophthalmology successfully held the 6th International Genomics Ophthalmology Congress in Shenyang, connecting global medical, educational, industrial, academic, research and investment resources, and promoting cross-border integration in different fields. In August, He's Ophthalmology and Liaoning He Medical College co-hosted the 16th Scientific Conference of the International Society of Ophthalmic Pharmacology and Therapeutics (AOPT) (China Branch). Also in August, the 5th China-Africa Eye Health Development Forum, co-hosted by He's Ophthalmology and a number of institutions, was held in Mombasa, Kenya, becoming a model for China's medical technology to go abroad.

With the original intention of "serving the country with science and technology, benefiting the people with technology", He's Ophthalmology has undoubtedly built a solid academic and technical foundation in the field of ophthalmology, and at the medical level, He's Ophthalmology has always adhered to the service concept and ingenuity of "sincere and moving", focusing on building a comprehensive medical service system and wholeheartedly providing customers with comprehensive medical and health services. For example, the company has innovatively built a digital quality control system to provide intelligent analysis tools for its subsidiaries to accurately analyze the three key data of customer relationship management, namely customer satisfaction, brand reputation and customer loyalty, and promote each branch to win the deep satisfaction and trust of customers with better service.

Science and technology for good, talent training to promote the development of the industry

Under the strategy of "Digital Bright City", medicine, education, production and research are undoubtedly important links, and what is supported by these four parts is the most prominent element of the strategy - social responsibility. Corporate social responsibility is not limited to promoting the development of the industry with academic research, nor is it limited to benefiting the people through business with cutting-edge technology.

Concerned about the disadvantaged, Ho's Ophthalmology provides eye health services for vulnerable groups such as children and the elderly by organizing various charity activities, and works together to promote social harmony and healthy development. For example, as a base for the prevention and control of myopia among adolescents in Liaoning Province, He's Ophthalmology has cooperated with the Shenyang Women's Federation to carry out a public welfare project on children's eye health, apply innovative technology, strengthen popular science education, help the implementation of the national myopia prevention and control strategy, and contribute to the eye health of children and adolescents in Shenyang. On the occasion of the Chung Yeung Festival, Dandong He's went to Dandong Nursing Home to carry out free clinic activities as a caring enterprise, providing free examinations and distributing glasses to the elderly.

Public welfare undertakings or few sparks, Ho's Ophthalmology has promoted the realization of "national health" in the field of ophthalmology from a broader and deeper dimension. As early as 2012, with the approval of the former Ministry of Health (now the "National Health Commission"), Shenyang Heshi has become the first national "Ministry of Health Blindness Prevention and Treatment Training Base", responsible for the national blindness prevention and treatment management and the training of ophthalmic professional and technical personnel, so far it has trained more than 50,000 community public health personnel, cataract small incision surgeons, eye nurses, optometry personnel, low vision rehabilitation physicians, blindness prevention management personnel, etc., covering all provinces except Hong Kong, Macao and Taiwan.

Since 2004, Ho's Ophthalmology has carried out long-term cooperation with Orbis International in the fields of blindness prevention training, capacity building, and care for vulnerable eye disease patients. In 2023, Ho's Ophthalmology invited Professor Liang Yulong, an internationally renowned ophthalmology expert, to jointly carry out the "Glaucoma New Technology Training Course", which conveyed the ophthalmic surgical skills and the theoretical basis behind it in the form of live surgery and theoretical teaching, attracting more than 950 participants.

Excellent talents have always been the shortcomings of ophthalmic medicine. Since 2001, He's Ophthalmology has established a joint training mechanism with China Medical University, Shenyang Pharmaceutical University, Dalian Medical University, Liaoning University of Traditional Chinese Medicine and other domestic medical universities, including ophthalmology, public health, pharmacy and other majors, aiming to jointly cultivate high-quality master's and doctoral students in line with the company's future strategic development. The Ophthalmology Congress of the International Genomics Congress held in 2023 also set up a special theme activity of "Scientists Dialogue with Medical Students", inviting Academician Fan Xianqun, Professor He Wei, Professor Pang Jijing and Dr. Wang Zhuoshi to have a passionate dialogue with the student representatives and 510,000 online students to encourage medical students to become innovative talents in the new era.

Governance and environmental protection work together to build sustainable development

A sound corporate governance system is an important guarantee for the sustainable development of the company. Focusing on corporate governance, He's Ophthalmology has paid sufficient attention to the leadership of party building, the operation of the three committees, information disclosure, the independence and diversity of the board of directors, and risk compliance, which has provided strong support for the long-term stability of the company.

Specifically, in terms of party building, He's Ophthalmology closely follows the general requirements of "learning ideas, strengthening party spirit, emphasizing practice, and making new contributions", deeply studies and practices the spirit of the 20th National Congress of the Communist Party of China, and holds a total of 28 general party branch activities and 1,296 party branch activities in 2023. In terms of information disclosure, a total of 129 disclosure announcements will be made in 2023, and the information disclosure level of the Shenzhen Stock Exchange will reach B. In terms of investor relations management, during the reporting period, the company visited 16 on-site reception institutions for research and exchange, answered more than 400 calls from investors, replied to 56 interactive questions and answers from the Shenzhen Stock Exchange, and successfully held online performance briefings.

It is worth mentioning that on the Board of Directors, Ho Ophthalmology adheres to the principle of meritocracy, taking into account diverse perspectives including but not limited to factors such as gender, age, culture and ethnicity. At present, the company's board of directors has extensive experience in the fields of law, finance, finance, medical and biomedical industries, and half of the directors hold relevant doctoral degrees.

As a consumer-oriented medical company, ensuring compliance and attaching importance to risk management construction are also the key tasks of He's Ophthalmology's corporate governance. During the reporting period, the company carried out 11 internal business trainings for the securities department and 2 legal compliance trainings for directors, supervisors and senior executives, fully ensuring that all levels attach importance to compliance. Furthermore, in June 2023, the company tailored a special training on public opinion and reputation management of listed companies for directors, supervisors, senior executives and related personnel, and invited industry experts to conduct a thorough discussion on the characteristics of the medical service industry, reputation risk mechanisms and coping strategies, so as to ensure that they can respond quickly and accurately when risk events occur, and comprehensively improve the participants' cognitive level of public opinion management.

In addition to corporate governance, environmental protection is also a concern of Ho's Ophthalmology. Ho Ophthalmology believes that everyone should be a guardian and beneficiary of the planet, and that companies have the ability and responsibility to actively promote environmental improvement. Taking the construction of a green hospital as an example, when promoting the construction of the hospital, He's Ophthalmology has always adhered to the concept of green development, fully implemented the principle of "construction according to law, safety first, and environmental protection first", and ensured that every construction activity meets the strict requirements of safe production, energy conservation and environmental protection.

Stick to the original intention and build a dream of He's

Adhering to the original intention of "serving the country with science and technology and benefiting the people with technology", the company's first ESG report shows readers the efforts and achievements of He's Ophthalmology in adhering to scientific and technological innovation, assuming social responsibility, and improving corporate governance from multiple dimensions over the past 20 years. Today, when the company is about to usher in the "year of establishment", He's Ophthalmology will also uphold long-termism, continue to stick to its original intention, and embrace change and continue to change with the determination and perseverance of always being on the road.

This ESG report also shows us the broad mind and social ideals of a medical company. The company clearly pointed out in the report that the business format that He's Ophthalmology will eventually achieve is not only a simple medical service, but a service ecology featuring ophthalmology for whole life health and chronic disease management with humanistic care as the original intention, relying on scientific and technological innovation, and based on the digital full life cycle health management platform.

It is precisely because of He's insistence on the original intention that we believe that the company will be able to make more scientific and technological innovation achievements benefit the people, continue to create value for the society, seek its own sustainable development in promoting social progress, and ultimately contribute the wisdom and strength from He's Ophthalmology to meet the needs of human beings for a better life.